New Diagnostic Criteria for Diabetes: Is the Change from Glucose to HbA1c Possible in All Populations?
新的糖尿病诊断标准：可能是所有人葡萄糖糖化血红蛋白的变化？
There was no difference in the HbA1c levels according to the tertiles of their fasting C-peptide level.
而在按照禁食C肽水平高低分级的各组，其糖化血红蛋白水平没有什么区别。
Does that increase HbA1C directly relate to the potential fetal mortality, or is more of a secondary result?
HbA1c升高是否与胎儿死亡风险增加直接相关，或者只是间接有关？
Will average glucose substitute glycosylated hemoglobin (HbA1c) as the gold standard of blood glucose evaluation?
平均血糖将取代糖化血红蛋白成为评价血糖的金标准？
I think current guidelines of target HbA1c levels of 6.5% are very sensible, and there is no evidence to go lower.
我认为现在指南中的6.5%的糖化血红蛋白标准6.5%很明智，没有证据要把糖化血红蛋白降得更低了。
To achieve this HbA1c goal, do you have any important experience or recommendations in the management of diabetic patients?
为了达到此目标，您对糖尿病患者的管理有什么最深的体会或建议吗？
Hemoglobin A1c (HbA1c) levels, which measure the control of blood glucose over time, were obtained from patients' medical charts.
用来衡量过去血糖控制情况的糖化血红蛋白(HbA1c)水平从病人的医疗图表中获取。
Changes in fasting plasma glucose levels were particularly marked among patients who had higher baseline HbA1c levels, Shai noted.
Shai指出，在基础hba1c水平较高的患者中，空腹血糖水平的变化特别显著。
HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
在短时间内单用二甲双胍血糖控制标识在青少年2型糖尿病患者的糖化血红蛋白。
Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients?
葡萄糖变异是否会影响1型和2型糖尿病患者平均血糖和糖化血红蛋白水平间的关系？
There is remarkable difference at decreasing blood sugar and HbA1c in the group, but there is not difference between the two groups(P>0.05).
糖络通在降低血糖、糖化血红蛋白方面均有较好的疗效，治疗前后比较有显著差异（P<0.05），但组间比较无差异性（P>0.05）。
Compared with the other two groups, the levels of blood glucose, cholesterol, trigalloyl glycerol, HbA1c in DM group increased significantly.
糖尿病维持组中血糖、胆固醇、甘油三酯、糖化血红蛋白明显高于糖尿病治疗组和正常对照组；
However, in a group of patients with highest postprandial C-peptide tertile, the HbA1c values were significantly lower than those in other groups.
然而，在餐后C肽水平最高的病人组，所测糖化血红蛋白水平却显著低于其他组。
He knows of other pediatric endocrinologists who use 10%, and still others who use an HbA1c closer to 8% as their threshold for turning to insulin.
他了解到其他小儿内分泌科医生中有些使用10%，还有些使用接近8%作为添加胰岛素治疗的阈值。
Since even a 10% decline in HbA1c level is associated with a reduction in complications such as eye and kidney problems, this is an impressive result.
因为如果糖化血红蛋白水平下降10%，眼部和肾脏的并发症发生率就会随之减少，为此这一试验结果使人倍受鼓舞。
Fasting plasma glucose, HbA1c, triglyceride, total cholesterol, low density lipid cholesterol and high density lipid cholesterol were measured in all cases.
检测所有患者的空腹血糖、糖化血红蛋白、血清甘油三酯、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇。
We hypothesized that there is an effect of intensive diabetes treatment, aimed at achieving normal HbA1c levels, on RHR in individuals with type 1 diabetes.
我们猜测目的旨在获得正常hba1c水平的强化治疗对于1型糖尿病患者的RHR有影响。
Results: HbA1c, fasting blood glucose and 2h plasma glucose were significant difference as compared to that before establishing the network management(P<0.01).
结果：空腹、餐后2h血糖、糖化血红蛋白与管理前比较有统计学意义（P<0.01）。
When a regimen is more possible to make HbA1c reach 6.5%, but the risk of hypoglycemia also increase, then safety and effect, which one would you like to choose?
当一个病人的治疗方案可使HbA1c更接近6.5%，但潜在低血糖的风险增加时，安全和达标，您更愿意选择那一项？
International Diabetes: a linear relationship between HbA1C and average blood glucose levels has been observed the ADAG study which was not influenced by age, gender, or race.
国际糖尿病：ADAG研究显示，平均血糖水平与糖化血红蛋白呈良好的线性相关，不受年龄、性别、种族的影响。
Onset age, body mass index, fasting blood glucose, HbA1C, high density lipoprotein-cholesterol and diabetic nephropathy could be related to occurrence of mtDNA mutations (P<0.05).
起病年龄、体重指数、空腹血糖、糖化血红蛋白、高密度脂蛋白和糖尿病肾病等指标是线粒体基因突变的相关因素（P<0.05）。
DM rats were randomly divided into cilostazol group and DM group. 8 weeks after treatment, blood glucose, body weight, HbA1c, cardiac weight index and ultrastructure of myocardiocyt were observed.
方法将DM大鼠随机分为西洛他唑治疗组和DM组，用药8周后检测两组血糖、体质量、糖化血红蛋白、心脏重量指数，观察其心肌细胞超微结构变化。
DM rats were randomly divided into cilostazol group and DM group. 8 weeks after treatment, blood glucose, body weight, HbA1c, cardiac weight index and ultrastructure of myocardiocyt were observed.
方法将DM大鼠随机分为西洛他唑治疗组和DM组，用药8周后检测两组血糖、体质量、糖化血红蛋白、心脏重量指数，观察其心肌细胞超微结构变化。
应用推荐